Study Says FDA Reviews New Drugs Faster Than EU, Canada
The U.S. Food and Drug Administration has significantly outpaced its European and Canadian counterparts over the past decade when it comes to reviewing new drugs, according to a study published Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article